Reduced antioxidant enzyme activity in brains of mice transgenic for human presenilin-1 with single or multiple mutations

Neuroscience Letters

Volumn 292, Issue 2, 2000, Pages 87-90

  Leutner, Silke ^a   Czech, Christian ^b   Schindowski, Katharina ^a   Touchet, Nathalie ^b   Eckert, Anne ^a   Müller, Walter E ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b SANOFI   (France)

Author keywords

Alzheimer's disease; Glutathione reductase; Lipid peroxidation; Presenilin; Reactive oxygen species; Superoxide dismutase

Indexed keywords

GLUTATHIONE REDUCTASE; PRESENILIN 1; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE MUTATION; HUMAN; LIPID PEROXIDATION; MOUSE; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; ANTIOXIDANTS; BRAIN; GLUTATHIONE REDUCTASE; HUMANS; LIPID PEROXIDATION; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MUTAGENESIS; NERVE DEGENERATION; PRESENILIN-1; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TRANSGENES;

EID: 0034613438     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01449-X     Document Type: Article

References (17)

1. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell. 77:1994;817-827.
2. Bursztajn S., DeSouza R., McPhie D.L., Berman S.A., Shioi J., Robakis N.K., Neve R.L. Overexpression in neurons of human presenilin-1 or a presenilin-1 familial Alzheimer disease mutant does not enhance apoptosis. J. Neurosci. 18:1998;9790-9799.
3. Chui D.H., Tanahashi H., Ozawa K., Ikeda S., Checler F., Ueda O., Suzuki H., Araki W., Inoue H., Shirotani K., Takahashi K., Gallyas F., Tabira T. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Natl. Med. 5:1999;560-564.
4. Citron M., Eckman C.B., Diehl T.S., Corcoran C., Ostaszewski B.L., Xia W., Levesque G., St.George H., Younkin S.G., Selkoe D.J. Additive effects of PS1 and APP mutations on secretion of the 42- residue amyloid beta-protein. Neurobiol. Dis. 5:1998;107-116.
5. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St.George H., Selkoe D.J. Mutant presenilins of Alzheimer's disease increase production of 42- residue amyloid beta-protein in both transfected cells and transgenic mice. Nat. Med. 3:1997;67-72.
6. Czech C., Delaere P., Macq A.F., Reibaud M., Dreisler S., Touchet N., Schombert B., Mazadier M., Mercken L., Theisen M., Pradier L., Octave J.N., Beyreuther K., Tremp G. Proteolytical processing of mutated human amyloid precursor protein in transgenic mice. Brain Res. Mol. Brain Res. 47:1997;108-116.
7. Czech C., Lesort M., Tremp G., Terro F., Blanchard V., Schombert B., Carpentier N., Dreisler S., Bonici B., Takashima A., Moussaoui S., Hugon J., Pradier L. Characterization of human presenilin 1 transgenic rats: increased sensitivity to apoptosis in primary neuronal cultures. Neuroscience. 87:1998;325-336.
8. Czech C., Tremp G., Pradier L. Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms. Prog. Neurobiol. 60:2000;363-384.
9. Guo Q., Sebastian L., Sopher B.L., Miller M.W., Ware C.B., Martin G.M., Mattson M.P. Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of superoxide production and caspase activation. J. Neurochem. 72:1999;1019-1029.
10. Holcomb L., Gordon M.N., McGowan E., Yu X., Benkovic S., Jantzen P., Wright K., Saad I., Mueller R., Morgan D., Sanders S., Zehr C., O'Campo K., Hardy J., Prada C.M., Eckman C., Younkin S., Hsiao K., Duff K. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4:1998;97-100.
11. Moussaoui S., Blanchard V., Bonici B., Czech C., Tremp G., Touchet N., Pradier L., Imperato A. Progression of neuropathology in several transgenic mice expressing a single gene or two genes linked to familial Alzheimer's disease: APP. PS-1 or both proteins, Soc. Neurosci. 25:1999;426.
12. Roperch J.P., Alvaro V., Prieur S., Tuynder M., Nemani M., Lethrosne F., Piouffre L., Gendron M.C., Israeli D., Dausset J., Oren M., Amson R., Telerman A. Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression. Nat. Med. 4:1998;835-838.
13. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2:1996;864-870.
14. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
15. Steiner H., Romig H., Grim M.G., Philipp U., Pesold B., Citron M., Baumeister R., Haass C. The biological and pathological function of the presenilin-1 Deltaexon 9 mutation is independent of its defect to undergo proteolytic processing. J. Biol. Chem. 274:1999;7615-7618.
16. Takahashi H., Mercken M., Honda T., Saito Y., Murayama M., Song S., Takashima A. Impaired proteolytic processing of presenilin-1 in chromosome 14-linked familial Alzheimer's disease patient lymphocytes. Neurosci. Lett. 260:1999;121-124.
17. Thinakaran G., Borchelt D.R., Lee M.K., Slunt H.H., Spitzer L., Kim G., Ratovitsky T., Davenport F., Nordstedt C., Seeger M., Hardy J., Levey A.I., Gandy S.E., Jenkins N.A., Copeland N.G., Price D.L., Sisodia S.S. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron. 17:1996;181-190.